Reviewed By
Infographics 
Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 10 Researches
7.9
USERS' SCORE
Good
Based on 3 Reviews
8.5
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Calcium (from Calcium-Magnesium Inositol Hexaphosphate)
100 mg
8%
Inositol Hexaphosphate (from Calcium-Magnesium Inositol Hexaphosphate)
500 mg
†
Top Medical Research Studies
8
We aimed to evaluate how myo-inositol supplementation affects women with gestational diabetes through a meta-analysis of randomized controlled trials. Our search included multiple databases, leading to the analysis of four studies involving 317 participants. The results showed that myo-inositol significantly reduced the need for insulin and improved insulin sensitivity. However, it did not influence birth weight, cesarean delivery rates, or NICU admissions. These findings suggest myo-inositol could be a helpful addition to managing gestational diabetes, but further research is needed.
Read More
9.5
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
Read More
8
Myo-inositol improves glycemic control
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
Read More
Most Useful Reviews
9.5
Life-changing product
5 people found this helpful
This product is almost a miracle for diabetes. I saw my fasting blood sugar levels drop dramatically, from 250 to 100, and I suspect that the FDA may soon take notice. This product truly works!
Read More
8.5
Effective for blood sugar
4 people found this helpful
This has been effective for my husband, who has type 2 diabetes. After three months on bitter melon capsules, his blood sugar levels decreased from the high 190s to the mid-150s. I chose Jarrow Formulas for its high-quality reputation and it seems to be working well.
Read More
7.5
Regulates blood sugar
3 people found this helpful
Health. Works well with my type 2 diabetes, regulating my blood.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 10 Researches
7.9
- All Researches
9.5
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
Read More
9
We evaluated the effectiveness of Xelaglifam, a new drug designed to activate specific receptors that help manage Type 2 diabetes. Our study compared its performance against another drug, Fasiglifam.
Through tests in the lab and on rats, we found that Xelaglifam boosts insulin secretion and lowers blood sugar levels effectively without causing hypoglycemia.
Additionally, its ability to improve glucose tolerance suggests it could be a valuable treatment option for those managing this condition, potentially working well alongside existing medications.
Through tests in the lab and on rats, we found that Xelaglifam boosts insulin secretion and lowers blood sugar levels effectively without causing hypoglycemia.
Additionally, its ability to improve glucose tolerance suggests it could be a valuable treatment option for those managing this condition, potentially working well alongside existing medications.
Read More
8
We explored the effects of ice plant extract and its compound D-pinitol on insulin secretion and blood sugar levels in diabetic rats. By utilizing the glucose-stimulated insulin secretion test and measuring various insulin-related factors, we discovered that both substances significantly boosted insulin secretion.
Additionally, ice plant extract helped reduce weight gain and improved glucose tolerance. These findings suggest that ice plant and D-pinitol could serve as beneficial functional foods for managing diabetes and supporting insulin signaling in the body.
Additionally, ice plant extract helped reduce weight gain and improved glucose tolerance. These findings suggest that ice plant and D-pinitol could serve as beneficial functional foods for managing diabetes and supporting insulin signaling in the body.
Read More
8
Histatin 1 enhances diabetic wound healing
We explored how Histatin 1, found in human saliva, helps combat aging in human umbilical vein endothelial cells (HUVECs) to improve diabetic wound healing. The study revealed that this peptide reduces cell senescence and works by enhancing mitochondrial function and reducing oxidative stress.
In laboratory settings, Histatin 1 decreased markers of aging in cells and improved their function. Furthermore, in a mouse model of diabetes, it promoted wound healing through increased blood vessel formation.
Overall, Histatin 1 shows promise as a solution for improving skin repair in diabetic patients.
In laboratory settings, Histatin 1 decreased markers of aging in cells and improved their function. Furthermore, in a mouse model of diabetes, it promoted wound healing through increased blood vessel formation.
Overall, Histatin 1 shows promise as a solution for improving skin repair in diabetic patients.
Read More
8
Myo-inositol improves glycemic control
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
Read More
User Reviews
USERS' SCORE
Good
Based on 3 Reviews
8.5
- All Reviews
- Positive Reviews
- Negative Reviews
9.5
Life-changing product
5 people found this helpful
This product is almost a miracle for diabetes. I saw my fasting blood sugar levels drop dramatically, from 250 to 100, and I suspect that the FDA may soon take notice. This product truly works!
Read More
8.5
Effective for blood sugar
4 people found this helpful
This has been effective for my husband, who has type 2 diabetes. After three months on bitter melon capsules, his blood sugar levels decreased from the high 190s to the mid-150s. I chose Jarrow Formulas for its high-quality reputation and it seems to be working well.
Read More
7.5
Regulates blood sugar
3 people found this helpful
Health. Works well with my type 2 diabetes, regulating my blood.
Read More
Frequently Asked Questions
8
We explored the effects of ice plant extract and its compound D-pinitol on insulin secretion and blood sugar levels in diabetic rats. By utilizing the glucose-stimulated insulin secretion test and measuring various insulin-related factors, we discovered that both substances significantly boosted insulin secretion.
Additionally, ice plant extract helped reduce weight gain and improved glucose tolerance. These findings suggest that ice plant and D-pinitol could serve as beneficial functional foods for managing diabetes and supporting insulin signaling in the body.
Additionally, ice plant extract helped reduce weight gain and improved glucose tolerance. These findings suggest that ice plant and D-pinitol could serve as beneficial functional foods for managing diabetes and supporting insulin signaling in the body.
8
Myo-inositol improves glycemic control
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
5
Myo-inositol's uncertain benefits for gestational diabetes
We examined how myo-inositol might help prevent gestational diabetes in overweight and obese pregnant women through a systematic review and meta-analysis of randomized controlled trials.
While some findings suggest that taking 4 grams of myo-inositol daily could lower the occurrence of gestational diabetes and other pregnancy-related complications, the evidence remains uncertain and lacks strong conclusions.
More high-quality studies are needed to understand its true effectiveness and safety better.
While some findings suggest that taking 4 grams of myo-inositol daily could lower the occurrence of gestational diabetes and other pregnancy-related complications, the evidence remains uncertain and lacks strong conclusions.
More high-quality studies are needed to understand its true effectiveness and safety better.
8
We explored the effects of myo-inositol (MI) on diabetes using db/db mice, a common model for type 2 diabetes. Our findings showed that MI successfully lowered high blood glucose and insulin levels while improving insulin resistance, performing similarly to metformin.
Additionally, MI reduced triglycerides and cholesterol, demonstrating its potential benefits for metabolic health. Although it inhibited the formation of fat cells from stem cells, MI did not address obesity in these mice. Overall, our study suggests that MI may be a valuable supplemental treatment for managing diabetes-associated conditions.
Additionally, MI reduced triglycerides and cholesterol, demonstrating its potential benefits for metabolic health. Although it inhibited the formation of fat cells from stem cells, MI did not address obesity in these mice. Overall, our study suggests that MI may be a valuable supplemental treatment for managing diabetes-associated conditions.
9.5
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.
Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
References
- Lee D, Kim SJ, Choi YJ, Rho YH, Kang TS, et al. The Glucose-Lowering Effect of and D-Pinitol: Studies on Insulin Secretion in INS-1 Cells and the Reduction of Blood Glucose in Diabetic Rats. Nutrients. 2025;17. 10.3390/nu17010193
- Xian T, Liu Y, Ye Y, Peng B, Huang J, et al. Human salivary histatin 1 regulating IP3R1/GRP75/VDAC1 mediated mitochondrial-associated endoplasmic reticulum membranes (MAMs) inhibits cell senescence for diabetic wound repair. Free Radic Biol Med. 2024;225:164. 10.1016/j.freeradbiomed.2024.09.046
- Asimakopoulos G, Pergialiotis V, Antsaklis P, Theodora M, Loutradis D, et al. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial. Arch Gynecol Obstet. 2024;310:1895. 10.1007/s00404-024-07618-8
- Chen H, Xiong J, Li Z, Chen Y, Zhang M, et al. Influence of myo-inositol on metabolic status for gestational diabetes: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2024;37:2228450. 10.1080/14767058.2023.2228450
- Yoon J, Lee DG, Song H, Hong D, Park JS, et al. Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes. Biomed Pharmacother. 2024;177:117044. 10.1016/j.biopha.2024.117044
- Long L, Huang Q, Song T, Dai Z. Myo-inositol rescued insulin resistance and dyslipidemia in db/db mice. J Appl Biomed. 2024;22:74. 10.32725/jab.2024.009
- Aguilar-Guadarrama AB, Díaz-Román MA, Osorio-García M, Déciga-Campos M, Rios MY. Chemical Constituents from Agave applanata and Its Antihyperglycemic, Anti-inflammatory, and Antimicrobial Activities Associated with Its Tissue Repair Capability. Planta Med. 2024;90:397. 10.1055/a-2270-5527
- Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, et al. Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Blume and Inulin in Patients with Metabolic Syndrome. Nutrients. 2024;16. 10.3390/nu16020249
- Factor PA, Corpuz H. The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. J ASEAN Fed Endocr Soc. 2023;38:102. 10.15605/jafes.038.02.11
- Greff D, Váncsa S, Váradi A, Szinte J, Park S, et al. Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2023;15. 10.3390/nu15194224
